Table II.

Comparison of electrocardiographic and echocardiographic findings between groups

Parameter	MHT (n = 72)	Control (n = 40)	P-value
LVH (based on ECG), present/absent, N	34/38	3/37	< 0.001***
IVST [mm]*	1.23 ±0.12	0.92 ±0.14	< 0.001**
PWT [mm]*	1.17 ±0.10	0.90 ±0.11	< 0.001**
RWT [mm]*	0.43 ±0.06	0.39 ±0.6	> 0.05**
LV mass [g]	193.23 ±12.21	165.42 ±10.42	< 0.001**
LV mass index****	103.57 ±7.24	86.73 ±8.75	< 0.001**
EF (%)	59.11 ±9.21	61.21 ±11.24	> 0.05**
LVDD, present/absent, N	25/47	5/35	< 0.001***
E/A ratio	0.91 ±0.15	1.21 ±1.02	< 0.001**

LVH – left ventricular hypertrophy, IVST – interventricular septum, EF – ejection fraction, LVDD – left ventricle diastolic dysfunction, PWT – posterior wall thickness, RWT – right ventricular wall thickness.

^*Mean ± standard deviation

^**p-value is based on one-way ANOVA test

^***p-value is based on chi-square test or Fisher’s exact test as appropriate.

^****LVH defined as LV mass index of > 116.0 in men and > 104.0 in women.